FDA to phase out animal testing with AI and lab-based models Press Coverage FDA to phase out animal testing with AI and lab-based models FDA aims to replace animal testing in drug development with AI and lab-based models, enhancing…CertaraApril 11, 2025
Model-informed Formulation Development: Bridging Experimental Data and Mechanistic Modeling On-Demand Webinar Model-informed Formulation Development: Bridging Experimental Data and Mechanistic Modeling Discover how predictive modeling and model-informed formulation development (MIFD) are accelerating drug development. Learn from…CertaraApril 11, 2025
Write Quicker PBPK Reports with the Simcyp Report Assistant Blog Write Quicker PBPK Reports with the Simcyp Report Assistant April 11, 2025 Writing a report for PBPK models can be an onerous process, especially…CertaraApril 11, 2025
Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities Press Release Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities RADNOR, PA — April 1st, 2025 – Certara, Inc. (Nasdaq: CERT), a global leader in…CertaraApril 1, 2025
MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants On-Demand Webinar MIDD’s Growing Role in Global Health: A Case Study of Primaquine Exposures in Lactating Women and Breastfed Infants Explore how model-informed drug development (MIDD) enhanced clinical lactation studies and supported global health policy…CertaraMarch 28, 2025
PBBM Educational Webinar Series (Part 1): The Basics of Drug Absorption in Drug Development – Why is Drug Absorption Essential? [Japanese Webinar] On-Demand Webinar PBBM Educational Webinar Series (Part 1): The Basics of Drug Absorption in Drug Development – Why is Drug Absorption Essential? [Japanese Webinar] Part 2 on July 17th : What is the Drug Absorption Model? Part 3 in…CertaraFebruary 27, 2025
Simcyp Version 24: Advancing PBPK capabilities and translating new science and technology into regulatory-accepted predictive modeling On-Demand Webinar Simcyp Version 24: Advancing PBPK capabilities and translating new science and technology into regulatory-accepted predictive modeling With the release of Version 24, the Simcyp Simulator introduces cutting-edge enhancements that further elevate…CertaraFebruary 7, 2025
Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards Publication Static Versus Dynamic Model Predictions of Competitive Inhibitory Metabolic Drug–Drug Interactions via Cytochromes P450: One Step Forward and Two Steps Backwards Predicting metabolic drug–drug interactions (DDIs) via cytochrome P450 enzymes (CYP) is essential in drug development,…CertaraDecember 12, 2024
Real-world application of physiologically based pharmacokinetic models in drug discovery Publication Real-world application of physiologically based pharmacokinetic models in drug discovery The utility of physiologically based pharmacokinetic (PBPK) models in support of drug development has been…CertaraNovember 22, 2024
Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women Publication Recent applications of pharmacometrics and systems pharmacology approaches to improve and optimize drug therapy for pregnant and lactating women The article "Recent Applications of Pharmacometrics and Systems Pharmacology Approaches to Improve and Optimize Drug…CertaraNovember 18, 2024